Award
National Institute of Allergy and Infectious Diseases R01AI187178-01A1
Curing chronic Toxoplasma infection with novel and potent protease inhibitors
Recipient
University of Michigan at Ann Arbor
Award Amount
$603,601.00
Ceiling
$603,601.00
Awarded
July 30, 2025
Identifier
R01AI187178-01A1
NIH grant awarded to University of Michigan at Ann Arbor for research on novel protease inhibitors to cure chronic Toxoplasma infection, funded by NIAID.
Description
The project focuses on developing drugs to treat chronic ocular Toxoplasma gondii infection. The project involves computational modeling, drug optimization, and in vivo testing in mice. The funding is provided by the National Institute of Allergy and Infectious Diseases (NIAID).